CKLF1-C27 TFA, a C-terminal peptide of CKLF1, binds to the CCR4 receptor and activates the ERK1/2 pathway. It can abrogate the effect of CKLF1 on cells by competing for the CCR4 receptor and shows significant effects on promoting proliferation in HUVECs. CKLF1-C27 TFA has the potential for psoriasis research [1].
Molecular Weight:
3310.8
Formula:
C153H244F3N39O39
Target:
ERK|||CCR
* VAT and and shipping costs not included. Errors and price changes excepted
